Your browser doesn't support javascript.
loading
A nationwide post-marketing survey of knowledge, attitudes and recommendations towards human papillomavirus vaccines among healthcare providers in China.
Xu, Xiaoqian; Wang, Yueyun; Liu, Yawen; Yu, Yanqin; Yang, Chunxia; Zhang, Yanyang; Hong, Ying; Wang, Yan; Zhang, Xingxing; Bian, Rui; Cao, Xian; Xu, Lili; Hu, Shangying; Zhao, Fanghui.
  • Xu X; Department of Cancer Epidemiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Wang Y; Department of Healthcare, Affiliated Shenzhen Maternity and Child Healthcare Hospital, Southern Medical University, Shenzhen, China.
  • Liu Y; Department of Epidemiology and Statistics, School of Public Health, Jilin University, Changchun, China.
  • Yu Y; School of Public Health, Baotou Medical College, Baotou, Inner Mongolia, China.
  • Yang C; Department of Epidemiology and Biostatistics, West China School of Public Health/West China Forth University Hospital, Sichuan University, Chengdu, China.
  • Zhang Y; Institute for Expanded Program on Immunization, Henan Provincial Center for Disease Control and Prevention, Zhengzhou, China.
  • Hong Y; Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, China.
  • Wang Y; Department of Cancer Institute, Affiliated Tumor Hospital of Xinjiang Medical University, Urumqi, China.
  • Zhang X; MRL Global Medical Affairs, MSD China, Shanghai, China.
  • Bian R; MRL Global Medical Affairs, MSD China, Shanghai, China.
  • Cao X; MRL Global Medical Affairs, MSD China, Shanghai, China.
  • Xu L; MRL Global Medical Affairs, MSD China, Shanghai, China.
  • Hu S; Department of Cancer Epidemiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Zhao F; Department of Cancer Epidemiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. Electronic address: zhaofangh@cicams.ac.cn.
Prev Med ; 146: 106484, 2021 05.
Article en En | MEDLINE | ID: mdl-33647350
ABSTRACT
Since licensure of human papillomavirus (HPV) vaccine in mainland China, little research has been conducted about healthcare providers' (HCPs) understanding and recommendation of HPV vaccine. A multi-stage convenience sample of Chinese HCPs (N = 5270) were surveyed, involving obstetrician-gynecologists, HCPs from Division of Expanded Program on Immunization (DEPI), Community Health Center (CHC) and other non-HPV closely related professions. Binary logistic regression was conducted to explore factors associated with knowledge and recommendation behaviors. Overall, HCPs showed basic HPV/HPV vaccine knowledge with median (interquartile range) score at 9.5 (7.5-11.6) out of 16 and relatively high recommendation behavior (74.8%). Identified knowledge gaps among HCPs included risk factors of HPV infection, best time to vaccinate, prophylactic functions of HPV vaccine and especially classification of low-risk and high-risk types. Profession-specific analysis in individual knowledge item showed HCPs from CHC were suboptimal on HPV while obstetrician-gynecologists were less competent on HPV vaccine knowledge. Obstetrician-gynecologists also recommended vaccination less frequently than HCPs from DEPI and CHC. Besides being key predictors of recommendation practice (2.74, 95% CI 2.34-3.21), knowledge shared independent determinants with recommendation behavior on age and ethnicity and additionally associated with education and title by itself. Findings highlight overall and profession-specific gaps on HPV and HPV vaccine knowledge and recommendation practice. Future education and training efforts should be profession-niche-targeting and focus much on HCPs with lower title or education background and from minorities.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Infecciones por Papillomavirus / Vacunas contra Papillomavirus Tipo de estudio: Guideline / Prognostic_studies / Qualitative_research / Risk_factors_studies Límite: Humans País como asunto: Asia Idioma: En Año: 2021 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Infecciones por Papillomavirus / Vacunas contra Papillomavirus Tipo de estudio: Guideline / Prognostic_studies / Qualitative_research / Risk_factors_studies Límite: Humans País como asunto: Asia Idioma: En Año: 2021 Tipo del documento: Article